Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis

OBJECTIVE: To compare persistence and adherence to triple therapy with the nonbiologic disease‐modifying antirheumatic drugs (DMARDs) methotrexate (MTX), hydroxychloroquine, and sulfasalazine, versus a tumor necrosis factor inhibitor (TNFi) plus MTX in patients with rheumatoid arthritis (RA). METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Sauer, Brian C., Teng, Chia‐Chen, Tang, Derek, Leng, Jianwei, Curtis, Jeffrey R., Mikuls, Ted R., Harrison, David J., Cannon, Grant W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207907/
https://www.ncbi.nlm.nih.gov/pubmed/27273801
http://dx.doi.org/10.1002/acr.22944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207907/
https://www.ncbi.nlm.nih.gov/pubmed/27273801
http://dx.doi.org/10.1002/acr.22944

Ejemplares similares